Notice of Participation in the “Group for Shaping the Future” organized bythe Japan Association of Healthcare Initiative
The Company is pleased to announce its participation in the “Group for Shaping the Future of Healthcare” organized by the Japan Association of Healthcare Initiative, with the aim of contributing to the development of the healthcare field, which will become increasingly important going forward.
■ Background of Participation
The “Group for Shaping the Future of Healthcare” was established against the backdrop of the growing importance of the healthcare field to maintain a balance between increasing healthy life expectancy in Japan and the country’s medical insurance system. Medicine, pharmaceuticals, and food constitute the core of healthcare, and it is necessary to build a three-dimensional relationship among them on an equal footing. At the same time, it is essential to promote prevention, treatment, and nursing care in an integrated manner, which requires efforts that transcend industry boundaries. The Company agrees with the purpose of the Group, which is to promote research to solve issues in the healthcare field with participating members from academia and various industries, and has decided to participate in the Group.
■ Main Research Contents
・The future of the healthcare field and preparation for it
・The state of the business sector that supports healthcare, identification of issues and their solutions, and future vision.
・The state of distribution that supports healthcare, identification of issues and their solutions, and future vision.
・Reorganization of healthcare-related business and distribution
・More practical and pragmatic research on strengthening governance, promoting compliance, etc.
■ Member
【Representative】 Nobuyuki Imanishi | Representative Director・Chairman, Japan Association of Health care Initiative |
Michiko Obara, Ph.D | Professor, Faculty of Pharmaceutical Sciences, Teikyo Heisei University |
Shinya Sugiura | Representative Director and President, SUGI MEDICAL CO., LTD. |
Akira Umada | President and Representative Director, TOHO PHARMACEUTICAL.,CO.LTD. |
Note: This document has been translated from the Japanese original for reference purposes only.
In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.